Article PDF
Avoid common mistakes on your manuscript.
Abbreviations
- CHD:
-
Coronary heart disease
- TG:
-
triglyceride
- PAI-1:
-
plasminogen-activator inhibitor-1
References
Jarrett RJ (1994) Why is insulin not a risk factor for coronary heart disease? Diabetologia 37: 945–947
Stout RW (1990) Insulin and atheroma: 20-yr perspective. Diabetes Care 13: 631–654
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1495–1607
Hollenbeck G, Reaven GM (1987) Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 64: 1169–1173
Reaven GM, Hollenbeck CB, Chen Y-DI (1989) Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32: 52–55
Reaven GM, Brand RJ, Chen Y-DI, Mathur AK, Goldfine I (1993) Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes 42: 1324–1332
Haffner SM, Stem MP, Hazuda HP, Mitchell BD, Patterson JK (1990) Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? J Amer Med Assoc 263: 2893–2898
Landin K, Tengvory L, Smith U (1990) Elevated fibrinogen and plasminogen activator (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 227: 273–278
Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 3: 416–422
Laws A, Reaven GM (1993) Insulin resistance and risk factors for coronary heart disease. In: Ferrannini E (ed) Clinical endocrinology and metabolism: insulin resistance and disease. Baillière Tindall, London, pp 1063–1078
Reaven GM, Chen Y-DI (1988) Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes/Metab Rev 4: 639–652
Reaven GM, Lerner RL, Stern MP, Farquhar JW (1967) Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 46: 1756–1767
Olefsky JM, Farquhar JW, Reaven GM (1974) Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57: 551–560
Tobey TA, Greenfield M, Kraemer F, Reaven GM (1981) Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165–171
Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstack J, Raskin P (1988) Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 37: 982–987
Olefsky JM, Reaven GM, Farquhar JW (1974) Effects of weight reduction on obesity: studies of carbohydrate and lipid metabolism, J Clin Invest 53: 64–76
Farquhar JW, Frank A, Gross RC, Reaven GM (1966) Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man. J Clin Invest 45: 1648–1656
Zavaroni I, Dall'Aglio E, Alpi O et al. (1985) Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55: 259–266
Laws A, Reaven GM (1992) Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Int Med 231: 25–30
Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WS, Krauss RM (1988) Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 260: 1917–1921
Patsch JR, Miesenböck G, Hopferwieser T et al. (1992) Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb 12: 1336–1345
Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM (1993) Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 92: 141–146
Chen Y-DI, Swami S, Skowronski R, Coulston A, Reaven GM (1993) Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 76: 172–177
Miller GJ, Miller NE (1975) Plasma-high-density-lipoprotein concentration and development of ischaemic heartdisease. Lancet I: 16–19
Castelli WP, Doyle JT, Gordon T et al. HDL cholesterol and other lipids in coronary heart disease. Circulation 55: 767–772
Manninen V, Tenkanen L, Koskinen P et al. (1992) Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki heart study: implications for treatment. Circulation 85: 37–45
Assmann G, Schulte H (1992) Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 70: 733–737
Hulley SB, Rosenman RH, Bawol RD, Brand RJ (1980) Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med 302: 1383–1389
Criqui MH, Heiss G, Cohn R et al. (1993) Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 328: 1220–1225
Austin MA (1991) Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11: 2–14
Reaven GM (1993) Are triglycerides important as a risk factor for coronary disease? Heart Dis Stroke 2: 44–48
Laws A, King AC, Haskell W, Reaven GM (1991) Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men. Arterioscler Thromb 11: 1636–1642
Juhan-Vague I, Alessi MC, Vague P (1991) Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 34: 457–462
Potter van Loon BJ, Kluft C, Radder JK, Blankenstein MA, Meinders AE (1993) The cardiovascular risk factor plasminogen activator inhibitor type I is related to insulin resistance. Metabolism 42: 945–949
Juhan-Vague I, Thompson SG, Jespersen J, on Behalf of the ECAT Angina Pectoris Study Group (1993) Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris. Arterioscler Thromb 13: 1865–1873
Hamsten A, Wiman B, Defaire U, Blomback M (1985) Increased plasma level of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313: 1557–1563
Jarrett RJ (1992) In defence of insulin: a critique of syndrome X. Lancet 340: 469–471
Reaven GM (1991) Relationship between insulin resistance and hypertension. Diabetes Care 14: 33–38
Ferrari P, Weidmann P, Shaw S et al. (1991) Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 91: 589–596
Facchini F, Chen Y-DI, Clinkingbeard C, Jeppesen J Reaven GM (1992) Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens 5: 694–699
Shamiss A, Carroll J, Rosenthal T (1992) Insulin resistance in secondary hypertension. Am J Hypertens 5: 26–28
Hwang I-S, Ho H, Hoffmann BB, Reaven GM (1987) Fructose-induced insulin and hypertension in rats. Hypertension 10: 512–516
Reaven GM, Ho H, Hoffman BB (1988) Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension 12: 129–132
Reaven GM, Ho H, Hoffmann BB (1989) Somatostatin inhibition of fructose-induced hypertension. Hypertension 14: 117–120
Reaven GM, Chang H (1991) Relationship between blood pressure, insulin concentration, and insulin action in SHR and WKY rats. Am J Hypertens 4: 34–38
Reaven GM, Twersky J, Chang H (1991) Abnormalities of carbohydrate and lipid metabolism in Dahl rats. Hypertension 18: 630–635
Dall'Aglio E, Tosini P, Ferrari P, Zavaroni I, Passeri M, Reaven GM (1991) Abnormalities of insulin and lipid metabolism in Milan hypertensive rats. Am J Hypertens 4: 773–775
Anderson EA, Mark AL (1993) The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 21: 136–141
Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt A, Gaillard CA (1990) Chronic hyperinsulinemia and blood pressure. Hypertension 15: 519–527
Brands MW, Hildebrandt DA, Mizelle HL, Hall JE (1991) Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol 260: R764-R768
Saad M, Lillioja S, Myomba BL et al. (1991) Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324: 733–739
Falkner B, Hulman S, Tennenbaum J, Kushner H (1990) Insulin resistance and blood pressure in young black men. Hypertension 16: 706–711
Falkner B, Hulman S, Kushner H (1993) Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks. Hypertension 22: 18–25
Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary-heart-disease risk and impaired glucose tolerance. Lancet i: 1373–1376
Vaccaro O, Ruth KJ, Stamler J (1992) Relationship of postload plasma glucose to mortality with 19-yr follow-up. Diabetes Care 13: 1328–1334
Sheu WH-H, Jeng C-Y, Shieh S-M et al. (1992) Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am J Hypertens 5: 444–448
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reaven, G.M., Laws, A. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 37, 948–952 (1994). https://doi.org/10.1007/BF00400953
Issue Date:
DOI: https://doi.org/10.1007/BF00400953